Ara 290 for treatment of small fiber neuropathy in sarcoidosis

Expert Opinion on Investigational Drugs

Volumn 23, Issue 4, 2014, Pages 541-550

  Van Velzen, Monique ^b   Heij, Lara ^b   Niesters, Marieke ^b   Cerami, Anthony ^b   Dunne, Ann ^b   Dahan, Albert ^a   Brines, Michael ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ARAIM PHARMACEUTICALS   (United States)

Author keywords

ARA 290; Innate repair receptor; Neuropathy; Pain; Phase II study; Sarcoidosis; Small fiber neuropathy.

Indexed keywords

ARA 290; ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

6 MINUTE WALK TEST; ARTICLE; BRIEF PAIN INVENTORY; CLINICAL EFFECTIVENESS; CORNEAL NERVE FIBER; DISEASE SEVERITY; DRUG DESIGN; ERYTHROPOIESIS; FIBER NEUROPATHY SCREENING LIST SCORE; FUNCTIONAL STATUS; HUMAN; INTRAEPIDERMAL NERVE FIBER DENSITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NERVE FIBER; NERVE FIBER C; NERVOUS SYSTEM PARAMETERS; PAIN ASSESSMENT; PAIN THRESHOLD; PERCEPTIVE THRESHOLD; PHASE 2 CLINICAL TRIAL (TOPIC); QUALITY OF LIFE; QUANTITATIVE SENSORY TESTING; QUESTIONNAIRE; SARCOIDOSIS; SCORING SYSTEM; SENSORY ANALYSIS; SKIN BIOPSY; SMALL FIBER NEUROPATHY; WARM DETECTION THRESHOLD;

ANALGESICS; ANIMALS; ERYTHROMELALGIA; HUMANS; NEURALGIA; OLIGOPEPTIDES; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 84896114590     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.2014.892072     Document Type: Article

References (45)

1. Hoitsma E, Reulen JP, de Baets M, et al. Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci 2004;227:119-30 (Pubitemid 39496808)
2. Heij L, Dahan A, Hoitsma E. Sarcoidosis and pain caused by small-fiber neuropathy. Pain Res Treat 2012;2012:256024
3. Tavee J, Culver D. Sarcoidosis and small-fiber neuropathy. Curr Pain Headache Rep 2011;15:201-6 .
4. Dworkin RH, O?Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010;85:S3-14
5. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005;118:289-305 (Pubitemid 41752987)
6. Niesters M, Swartjes M, Heij L, et al. The erythropoietin analog ARA 290 for treatment of sarcoidosis-induced chronic neuropathic pain. Expert Opin Orphan Drugs 2013;1:77-87
7. Pulman KG, Smith M, Mengozzi M, et al. The erythropoietin-derived peptide ARA290 reverses mechanical allodynia in the neuritis model. Neuroscience 2013;233:174-83
8. Swartjes M, Morariu A, Niesters M, et al. ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain: an experimental study in rats and beta-common receptor knockout mice. Anesthesiology 2011;115:1084-92 .
9. Bianchi R, Brines M, Lauria G, et al. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity. Clin Cancer Res 2006;12:2607-12
10. Dahan A, Dunne A, Swartjes M, et al. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density. Mol Med 2013;18:334-45
11. Heij L, Niesters M, Swartjes M, et al. Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study. Mol Med 2012;18:1430-6
12. Chen ES, Moller DR. Sarcoidosis-scientific progress and clinical challenges. Nat Rev Rheumatol 2011;7:457-67
13. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-65
14. Costabel U. Sarcoidosis: clinical update. Eur Respir J Suppl 2001;32:56s-68s (Pubitemid 34755186)
15. Bakkers M, Merkies IS, Lauria G, et al. Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 2009;73:1142-8
16. Hoitsma E, Marziniak M, Faber CG, et al. Small fibre neuropathy in sarcoidosis. Lancet 2002;359:2085-6 (Pubitemid 34680974)
17. Hoitsma E, De Vries J, Drent M. The small fiber neuropathy screening list: construction and cross-validation in sarcoidosis. Respir Med 2011;105:95-100
18. Maier C, Baron R, Tolle TR, et al. Quantitative sensory testing in the german research network on neuropathic pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010;150:439-50
19. Grill JD, Coghill RC. Transient analgesia evoked by noxious stimulus offset. J Neurophysiol 2002;87:2205-8 (Pubitemid 34670783)
20. Niesters M, Dahan A, Swartjes M, et al. Effect of ketamine on endogenous pain modulation in healthy volunteers. Pain 2011;152:656-63
21. Niesters M, Hoitsma E, Sarton E, et al. Offset analgesia in neuropathic pain patients and effect of treatment with morphine and ketamine. Anesthesiology 2011;115:1063-71
22. Yelle MD, Rogers JM, Coghill RC. Offset analgesia: a temporal contrast mechanism for nociceptive information. Pain 2008;134:174-86 (Pubitemid 350253137)
23. England JD, Gronseth GS, Franklin G, et al. Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve 2009;39:106-15
24. Tavee J, Zhou L. Small fiber neuropathy: a burning problem. Cleve Clin J Med 2009;76:297-305
25. Bakkers M, Faber CG, Drent M, et al. Pain and autonomic dysfunction in patients with sarcoidosis and small fibre neuropathy. J Neurol 2010;257:2086-90
26. Gemignani F, Giovanelli M, Vitetta F, et al. Non-length dependent small fiber neuropathy. a prospective case series. J Peripher Nerv Syst 2010;15:57-62
27. Hoitsma E, Drent M, Verstraete E, et al. Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis. Clin Neurophysiol 2003;114:2326-33 (Pubitemid 37494929)
28. Brines M, Swartjes M, Tannemaat MR, et al. Corneal nerve quantification predicts the severity of symptoms in sarcoidosis patients with painful neuropathy. Technology 2013;1-1:7 .
29. Tavakoli M, Hossain P, Malik RA. Clinical applications of corneal confocal microscopy. Clin Ophthalmol 2008;2:435-45
30. Tavakoli M, Malik RA. Corneal confocal microscopy: a novel non-invasive technique to quantify small fibre pathology in peripheral neuropathies. J Vis Exp 2011; Epub ahead of print
31. Tavakoli M, Quattrini C, Abbott C, et al. Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 2010;33:1792-7
32. Patel DV, McGhee CN. In vivo laser scanning confocal microscopy confirms that the human corneal sub-basal nerve plexus is a highly dynamic structure. Invest Ophthalmol Vis Sci 2008;49:3409-12
33. Brines M, Grasso G, Fiordaliso F, et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA 2004;101:14907-12 (Pubitemid 39410773)
34. Liao ZB, Zhi XG, Shi QH, He ZH. Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats. Eur J Neurol 2008;15:140-9
35. Corwin HL, Gettinger A, Fabian TC, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 2007;357:965-76 (Pubitemid 47367076)
36. Bianchi R, Buyukakilli B, Brines M, et al. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci USA 2004;101:823-8 (Pubitemid 38121042)
37. Leist M, Ghezzi P, Grasso G, et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 2004;305:239-42 (Pubitemid 38886736)
38. Brines M, Cerami A. The receptor that tames the innate immune response. Mol Med 2012;18:486-96
39. Swartjes M, Niesters M, Heij L, et al. Ketamine does not produce relief of neuropathic pain in mice lacking the beta-common receptor (CD131). PLoS One 2013;8:e71326.
40. Martini CH, Yassen A, Krebs-Brown A, et al. A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia. Eur J Pain 2013;17:1491-501
41. Leung L, Cahill CM. TNF-alpha and neuropathic pain-a review. J Neuroinflammation 2010;7:27
42. Sigtermans MJ, van Hilten JJ, Bauer MC, et al. Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain 2009;145:304-11
43. Hoitsma E, Faber CG, van Santen-Hoeufft M, et al. Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab. Sarcoidosis Vasc Diffuse Lung Dis 2006;23:73-7 (Pubitemid 44259213)
44. Parambil JG, Tavee JO, Zhou L, et al. Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis. Respir Med 2011;105:101-5
45. Niesters M, Aarts L, Sarton E, Dahan A. Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebocontrolled cross-over proof-of-concept study. Br J Anaesth 2013;110:1010-16